200 related articles for article (PubMed ID: 23295467)
1. 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.
Slominski A; Janjetovic Z; Tuckey RC; Nguyen MN; Bhattacharya KG; Wang J; Li W; Jiao Y; Gu W; Brown M; Postlethwaite AE
J Clin Endocrinol Metab; 2013 Feb; 98(2):E298-303. PubMed ID: 23295467
[TBL] [Abstract][Full Text] [Related]
2. Antifibrogenic Activities of CYP11A1-derived Vitamin D3-hydroxyderivatives Are Dependent on RORγ.
Janjetovic Z; Postlethwaite A; Kang HS; Kim TK; Tuckey RC; Crossman DK; Qayyum S; Jetten AM; Slominski AT
Endocrinology; 2021 Jan; 162(1):. PubMed ID: 33107570
[TBL] [Abstract][Full Text] [Related]
3. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
Tuckey RC; Li W; Shehabi HZ; Janjetovic Z; Nguyen MN; Kim TK; Chen J; Howell DE; Benson HA; Sweatman T; Baldisseri DM; Slominski A
Drug Metab Dispos; 2011 Sep; 39(9):1577-88. PubMed ID: 21677063
[TBL] [Abstract][Full Text] [Related]
4. Modulation by 17,20S(OH)
Brown Lobbins ML; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Tuckey RC; Scott IO; Myers LK; Postlethwaite AE
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008794
[TBL] [Abstract][Full Text] [Related]
5. 17,20S(OH)
Brown Lobbins ML; Scott IO; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Patel TS; Myers LK; Postlethwaite AE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445632
[TBL] [Abstract][Full Text] [Related]
6. Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models.
Skobowiat C; Oak AS; Kim TK; Yang CH; Pfeffer LM; Tuckey RC; Slominski AT
Oncotarget; 2017 Feb; 8(6):9823-9834. PubMed ID: 28039464
[TBL] [Abstract][Full Text] [Related]
7. Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3.
Cheng CYS; Kim TK; Jeayeng S; Slominski AT; Tuckey RC
J Steroid Biochem Mol Biol; 2018 Mar; 177():59-69. PubMed ID: 28716760
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 and 20-Hydroxyvitamin D3 Upregulate LAIR-1 and Attenuate Collagen Induced Arthritis.
Myers LK; Winstead M; Kee JD; Park JJ; Zhang S; Li W; Yi AK; Stuart JM; Rosloniec EF; Brand DD; Tuckey RC; Slominski AT; Postlethwaite AE; Kang AH
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948139
[TBL] [Abstract][Full Text] [Related]
10. 20
Postlethwaite AE; Tuckey RC; Kim TK; Li W; Bhattacharya SK; Myers LK; Brand DD; Slominski AT
Front Immunol; 2021; 12():678487. PubMed ID: 34276665
[TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity.
Li W; Chen J; Janjetovic Z; Kim TK; Sweatman T; Lu Y; Zjawiony J; Tuckey RC; Miller D; Slominski A
Steroids; 2010 Dec; 75(12):926-35. PubMed ID: 20542050
[TBL] [Abstract][Full Text] [Related]
12. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
[TBL] [Abstract][Full Text] [Related]
13. Total synthesis of biologically active 20S-hydroxyvitamin D3.
Wang Q; Lin Z; Kim TK; Slominski AT; Miller DD; Li W
Steroids; 2015 Dec; 104():153-62. PubMed ID: 26433048
[TBL] [Abstract][Full Text] [Related]
14. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.
Zbytek B; Janjetovic Z; Tuckey RC; Zmijewski MA; Sweatman TW; Jones E; Nguyen MN; Slominski AT
J Invest Dermatol; 2008 Sep; 128(9):2271-80. PubMed ID: 18368131
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
[TBL] [Abstract][Full Text] [Related]
16. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains.
Oi M; Yamamoto T; Nishioka K
J Med Dent Sci; 2004 Mar; 51(1):7-17. PubMed ID: 15137460
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
19. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
Zhu L; Song Y; Li M
J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
[TBL] [Abstract][Full Text] [Related]
20. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.
Slominski AT; Janjetovic Z; Fuller BE; Zmijewski MA; Tuckey RC; Nguyen MN; Sweatman T; Li W; Zjawiony J; Miller D; Chen TC; Lozanski G; Holick MF
PLoS One; 2010 Mar; 5(3):e9907. PubMed ID: 20360850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
